Savara, Inc. (SVRA)
5.565
-0.02
(-0.45%)
USD |
NASDAQ |
Aug 24, 16:00
5.565
0.00 (0.00%)
After-Hours: 20:00
Savara Total Assets (Quarterly) : 192.14M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 192.14M |
| March 31, 2026 | 221.64M |
| December 31, 2025 | 253.44M |
| September 30, 2025 | 140.92M |
| June 30, 2025 | 163.76M |
| March 31, 2025 | 189.32M |
| December 31, 2024 | 212.88M |
| September 30, 2024 | 238.82M |
| June 30, 2024 | 139.67M |
| March 31, 2024 | 158.30M |
| December 31, 2023 | 177.56M |
| September 30, 2023 | 182.07M |
| June 30, 2023 | 119.83M |
| March 31, 2023 | 129.36M |
| December 31, 2022 | 139.78M |
| September 30, 2022 | 147.76M |
| June 30, 2022 | 156.78M |
| March 31, 2022 | 166.21M |
| December 31, 2021 | 176.60M |
| September 30, 2021 | 187.27M |
| June 30, 2021 | 196.43M |
| March 31, 2021 | 207.63M |
| December 31, 2020 | 97.74M |
| September 30, 2020 | 109.34M |
| June 30, 2020 | 115.15M |
| Date | Value |
|---|---|
| March 31, 2020 | 119.98M |
| December 31, 2019 | 136.20M |
| September 30, 2019 | 140.63M |
| June 30, 2019 | 147.33M |
| March 31, 2019 | 148.26M |
| December 31, 2018 | 155.38M |
| September 30, 2018 | 155.12M |
| June 30, 2018 | 117.94M |
| March 31, 2018 | 128.87M |
| December 31, 2017 | 160.09M |
| September 30, 2017 | 118.89M |
| June 30, 2017 | 125.77M |
| March 31, 2017 | 13.88M |
| December 31, 2016 | 29.19M |
| September 30, 2016 | 40.12M |
| June 30, 2016 | 47.68M |
| March 31, 2016 | 50.14M |
| December 31, 2015 | 54.22M |
| September 30, 2015 | 63.44M |
| June 30, 2015 | 56.76M |
| March 31, 2015 | 62.72M |
| December 31, 2014 | 70.50M |
| September 30, 2014 | 56.16M |
| June 30, 2014 | 59.37M |
| March 31, 2014 | 62.36M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 49.36B |
| Insmed, Inc. | 2.103B |
| United Therapeutics Corp. | 7.220B |
| Vertex Pharmaceuticals, Inc. | 27.42B |
| SELLAS Life Sciences Group, Inc. | 145.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 48.48M |
| Shareholders Equity (Quarterly) | 143.66M |
| Debt to Equity Ratio | 0.2117 |
| Current Ratio | 10.13 |
| Net Debt Paydown Yield | -0.01% |